Investigation of the effect of homocysteinylation of substance P on its binding to the NK1 receptor using molecular dynamics simulation
- PMID: 29943287
- DOI: 10.1007/s00894-018-3695-7
Investigation of the effect of homocysteinylation of substance P on its binding to the NK1 receptor using molecular dynamics simulation
Abstract
Substance P is a neurotransmitter or modulator in both the central and peripheral nervous systems. In this work, modifications of the lysine in SP by homocysteine and an acetyl group as well as the conformational dynamics of the native and modified SP peptides and their complexes with the NK1 receptor were studied via MD simulation. It was found that modifying SP stabilizes the peptide structure, but the modified SP peptides are less likely to bind to the NK1 receptor, so the resulting complexes are less stable. The RMSD of native SP (~0.33 nm) is about twice as large as that of the modified SP peptides (~0.18 nm), while the RMSD for the receptor complexed with native SP is ~0.3 nm, and that for the receptor complexed with either of the modified peptides is ~0.35 nm, which demonstrates the high stability of the modified SP peptides as well as the receptor complexed with native SP. Such behavior was also observed in other structural analyses. The binding free energies of the native and modified SP peptides with the NK1 receptor were also compared. The ΔGbind values for the binding of homocysteinylated SP to the NK1 receptor and the binding of the acetylated SP and native SP to the NK1 receptor were -38.89, -64.46, and - 264.52 kJ mol-1, respectively. Modification of the lysine of SP decreases the binding affinity of the peptide to the NK1 receptor. In other words, homocysteinylation or acetylation of SP leads to weaker interactions of the peptide with the NK1 receptor compared to those between native SP and NK1. We propose that this phenomenon leads to increased levels of homocysteinylated SP in plasma in many diseases such as breast cancer. Graphical abstract Substance P (SP) is a neuropeptide which binds to the NK1 receptor. SP is of great pharmacological interest, as agonists and antagonists of SP can potentially be used to treat many chronic diseases. Therefore, in this work, the lysine (LYS) in SP was theoretically modified with a homocysteine or acetyl group to explore the effects of such a modification on the binding affinity of this peptide with the NK1 receptor and the structural dynamics of the resulting complex.
Keywords: Acetyl; Homocysteine; Homocysteinylation; MD simulation; NK1 receptor; Substance P.
Similar articles
-
N- and C-terminal substance P fragments: differential effects on striatal [3H]substance P binding and NK1 receptor internalization.Neuroreport. 1999 Jul 13;10(10):2209-13. doi: 10.1097/00001756-199907130-00038. Neuroreport. 1999. PMID: 10424700
-
Point mutation increases a form of the NK1 receptor with high affinity for neurokinin A and B and septide.Br J Pharmacol. 1998 Sep;125(2):393-401. doi: 10.1038/sj.bjp.0702070. Br J Pharmacol. 1998. PMID: 9786514 Free PMC article.
-
Systematic study of substance P analogs. II. Rapid screening of 512 substance P stereoisomers for binding to NK1 receptor.Int J Pept Protein Res. 1993 Oct;42(4):392-9. Int J Pept Protein Res. 1993. PMID: 7503964
-
Substance P and neurokinin 1 receptor are new targets for the treatment of chronic pruritus.Br J Dermatol. 2019 Nov;181(5):932-938. doi: 10.1111/bjd.18025. Epub 2019 Jun 6. Br J Dermatol. 2019. PMID: 31016733 Review.
-
From the Anti-Nociceptive Substance P Metabolite Substance P (1-7) to Small Peptidomimetics.Curr Protein Pept Sci. 2018;19(11):1038-1048. doi: 10.2174/1389203719666180508122019. Curr Protein Pept Sci. 2018. PMID: 29745331 Review.
Cited by
-
Binding interactions of epididymal protease inhibitor and semenogelin-1: a homology modeling, docking and molecular dynamics simulation study.PeerJ. 2019 Aug 5;7:e7329. doi: 10.7717/peerj.7329. eCollection 2019. PeerJ. 2019. PMID: 31404433 Free PMC article.
-
Hypoglycemic effects and chemical changes of mulberry fruits of different ripeness: In vitro and silico studies.Food Chem X. 2025 Jul 23;29:102827. doi: 10.1016/j.fochx.2025.102827. eCollection 2025 Jul. Food Chem X. 2025. PMID: 40761754 Free PMC article.
-
Oroxin A suppresses non-small cell lung cancer via the HSP90AA1/AKT signaling pathway.Naunyn Schmiedebergs Arch Pharmacol. 2025 Aug 20. doi: 10.1007/s00210-025-04520-1. Online ahead of print. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 40833599
-
The Repurposing of Non-Peptide Neurokinin-1 Receptor Antagonists as Antitumor Drugs: An Urgent Challenge for Aprepitant.Int J Mol Sci. 2023 Nov 3;24(21):15936. doi: 10.3390/ijms242115936. Int J Mol Sci. 2023. PMID: 37958914 Free PMC article. Review.
-
How Do Molecular Dynamics Data Complement Static Structural Data of GPCRs.Int J Mol Sci. 2020 Aug 18;21(16):5933. doi: 10.3390/ijms21165933. Int J Mol Sci. 2020. PMID: 32824756 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources